"Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial." The Lancet Neurology , 9(4), 373-380.
Retatrutide is a pharmaceutical compound under clinical investigation (by Eli Lilly) that acts on three hormone receptors (GIP, GLP-1, and glucagon) to reduce appetite and body weight
Improved Insulin Sensitivity Semaglutide and Tirzepatide both help improve insulin sensitivity, meaning your body can use insulin more effectively
Extended tirzepatide use requires more than just tracking weight: metabolic markers, cardiovascular indicators, and genetic predispositions all inform whether long-term continuation aligns with your health goals
The purpose of this page is to provide clear procurement information for research buyers
The SURMOUNT-4 randomized clinical trial found that adults who continued tirzepatide maintained and improved weight reduction, while those switched to placebo regained weight
